These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 17727555)

  • 1. Myeloproliferative disorders: a time of new definitions. Outflow from New Horizons in Haematology Meeting, 9-10 March 2007.
    Skoda R; Barbui T; Reilly JT
    Eur J Haematol Suppl; 2007 Oct; (68):1. PubMed ID: 17727555
    [No Abstract]   [Full Text] [Related]  

  • 2. Proceedings from the New Horizons in Haematology Meeting, 9-10 March 2007.
    Eur J Haematol Suppl; 2007 Oct; (68):1-42. PubMed ID: 18175381
    [No Abstract]   [Full Text] [Related]  

  • 3. Proceedings from the 1st Insights in Hematology Symposium, Cluj-Napoca, Romania March 11-12, 2016.
    Bojan A; Berindan-Neagoe I; Ciurea S; Dima D; Fuji S; Ghiaur G; Grewal R; Mccormack E; Tanase A; Trifa A; Tomuleasa C
    Rom J Intern Med; 2016 Sep; 54(3):157-160. PubMed ID: 27658163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Haematology and oncology: in the vanguard of modern medicine].
    Ho AD; Hiddemann W
    Dtsch Med Wochenschr; 2009 Sep; 134(39):1921. PubMed ID: 19760550
    [No Abstract]   [Full Text] [Related]  

  • 5. [Picture in clinical hematology: subcorneal pustular dermatosis complicated with a myeloproliferative disorder].
    Ono H
    Rinsho Ketsueki; 2006 Nov; 47(11):1413. PubMed ID: 17176882
    [No Abstract]   [Full Text] [Related]  

  • 6. [Centralization versus decentralization. Hematology].
    Borregaard N
    Ugeskr Laeger; 2006 Apr; 168(15):1551-2. PubMed ID: 16640979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Highlights in myeloproliferative neoplasms from the 60th American Society of Hematology Annual Meeting: commentary.
    Mesa RA
    Clin Adv Hematol Oncol; 2019 Jan; 17 Suppl 2(1):18-19. PubMed ID: 31545310
    [No Abstract]   [Full Text] [Related]  

  • 8. Medicine in Malaysia: haematology.
    Cheong SK; Lopez CG
    Med J Malaysia; 1995 May; 50 Suppl A():S46-50. PubMed ID: 10968015
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical applications of molecular haematology: flow cytometry in leukaemias and myelodysplastic syndromes.
    Dalal BI
    J Assoc Physicians India; 2007 Aug; 55():571-3. PubMed ID: 18019799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Recent advances in haematology and oncology].
    Jäger U; Hiddemann W
    Dtsch Med Wochenschr; 2008 Oct; 133(41):2077. PubMed ID: 18985558
    [No Abstract]   [Full Text] [Related]  

  • 11. Palliative care in haematology.
    Joske D; McGrath P
    Intern Med J; 2007 Sep; 37(9):589-90. PubMed ID: 17714201
    [No Abstract]   [Full Text] [Related]  

  • 12. Haematologists specializing in the treatment of MPDs coordinated a combined effort with experts in other fields, in this case cardiology, dermatology and psychiatry. Introduction.
    Rønnov-Jessen D
    Hematol Oncol; 2009 Jun; 27 Suppl 1():1. PubMed ID: 19468980
    [No Abstract]   [Full Text] [Related]  

  • 13. New insights into the pathogenesis and treatment of chronic myeloproliferative disorders.
    Mesa RA
    Curr Opin Hematol; 2008 Mar; 15(2):121-6. PubMed ID: 18300758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Future vision of haematology].
    Degos L
    Presse Med; 2004 Jun; 33 Spec No():Sp64-6. PubMed ID: 15360151
    [No Abstract]   [Full Text] [Related]  

  • 15. [Achievements and developmental prospects in clinical hematology].
    Faĭnshteĭn FE
    Probl Gematol Pereliv Krovi; 1982 Nov; 27(11):3-10. PubMed ID: 7156079
    [No Abstract]   [Full Text] [Related]  

  • 16. Haematology. Important steps forward.
    Montserrat E; Rozman C
    Lancet; 1998 Dec 19-26; 352 Suppl 4():SIV13. PubMed ID: 9872160
    [No Abstract]   [Full Text] [Related]  

  • 17. The myeloproliferative neoplasms: insights into molecular pathogenesis and changes in WHO classification and criteria for diagnosis.
    Anastasi J
    Hematol Oncol Clin North Am; 2009 Aug; 23(4):693-708. PubMed ID: 19577165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New perspectives in managing myeloproliferative disorders: focus on the patient.
    Birgegård G
    Hematol Oncol; 2009 Jun; 27 Suppl 1():5-7. PubMed ID: 19468983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The future of haematology: inspiring others to join us on our noble journeys.
    Butler T
    Br J Haematol; 2020 Nov; 191(4):634-635. PubMed ID: 33190249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Tyrosine kinase inhibitors in the treatment of polycythemia vera and related conditions. Danish Society of Hematology].
    Larsen TS; Hasselbalch HC;
    Ugeskr Laeger; 2008 Mar; 170(12):1031. PubMed ID: 18397649
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.